RBPJ and B-cell chronic lymphocytic leukemia: Therefore we tested alternatively the therapeutic potential of gliotoxin which is a potent inhibitor of canonical NOTCH2/CSL signaling and which also induced apoptosis in CLL cells under microenvironment conditions in co-culture with primary bone marrow stromal cells (Shehata et al., 2010; Hubmann et al., 2013).